ijms-logo

Journal Browser

Journal Browser

Molecular Approaches Fighting Nonsense II

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Genetics and Genomics".

Deadline for manuscript submissions: closed (31 October 2023) | Viewed by 2517

Special Issue Editors


E-Mail
Guest Editor
Dipartimento di Scienze e Tecnologie Biologiche, Chimiche e Farmaceutiche (STEBICEF), Università di Palermo, Viale delle Scienze Ed. 17, Parco d'Orleans, 90128 Palermo, Italy
Interests: synthesis of heterocyclic compounds; heterocyclic chemistry; medicinal and pharmaceutical chemistry; synthetic medicinal chemistry; natural product chemistry; materials chemistry; applied organic chemistry
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Dipartimento di Scienze e Tecnologie Biologiche, Chimiche e Farmaceutiche, Università degli Studi di Palermo , Viale delle Scienze Ed. 17, 90128 Palermo, Italy
Interests: Caffeine; CFTR protein; drug

Special Issue Information

Dear Colleagues,

Nonsense mutations are a genetic change involved in about 10% of genetic diseases (cystic fibrosis, Duchenne muscular dystrophy, b-thalassemia, retinitis pigmentosa, congenital blindness, dystonia, spinal muscular atrophy, neurofibromatosis, lysosomal storage disease, Usher’s syndrome, hemophilia, Tay–Sachs disease, Schwackman Diamond syndrome, etc.).

This change causes the formation of a premature termination codon (PTC) in the mRNA encoded by a specific gene. This particular class of mutations is usually associated with a reduction in the level of cytoplasmic mRNA by the nonsense-mediated decay pathway (NMD).Therefore, the main problem caused by this genetic alteration is twofold: on the one hand, the reduced concentration of transcript, and on the other hand, the production of an unfunctional truncated polypeptide. To overcome these problems, different approaches have been proposed. One of the first strategies proposed is the readthrough approach, with the identification and use of small molecules, named translational readthrough-inducing drugs (TRIDs), allowing the overcoming of the premature stop codon. Another way is genetic editing by CRISPR technology, working on the genetic defect. Finally, a very recent emergent approach is the use of synthetic tRNA, able to recognize the premature stop codon during the translation process.

Pharmacological approaches to nonsense suppression are a fascinating field in view of a wider application to different genetic diseases whose common denominator is the presence of a premature stop codon in the mRNA.

In this Special Issue, we aim to collect different contributions in the form of recent and innovative research in the field of nonsense mutations.

Dr. Ivana Pibiri
Dr. Laura Lentini
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

19 pages, 9507 KiB  
Article
Investigating the Inhibition of FTSJ1, a Tryptophan tRNA-Specific 2′-O-Methyltransferase by NV TRIDs, as a Mechanism of Readthrough in Nonsense Mutated CFTR
by Pietro Salvatore Carollo, Marco Tutone, Giulia Culletta, Ignazio Fiduccia, Federica Corrao, Ivana Pibiri, Aldo Di Leonardo, Maria Grazia Zizzo, Raffaella Melfi, Andrea Pace, Anna Maria Almerico and Laura Lentini
Int. J. Mol. Sci. 2023, 24(11), 9609; https://doi.org/10.3390/ijms24119609 - 1 Jun 2023
Cited by 3 | Viewed by 1957
Abstract
Cystic Fibrosis (CF) is an autosomal recessive genetic disease caused by mutations in the CFTR gene, coding for the CFTR chloride channel. About 10% of the CFTR gene mutations are “stop” mutations that generate a premature termination codon (PTC), thus synthesizing a truncated [...] Read more.
Cystic Fibrosis (CF) is an autosomal recessive genetic disease caused by mutations in the CFTR gene, coding for the CFTR chloride channel. About 10% of the CFTR gene mutations are “stop” mutations that generate a premature termination codon (PTC), thus synthesizing a truncated CFTR protein. A way to bypass PTC relies on ribosome readthrough, which is the ribosome’s capacity to skip a PTC, thus generating a full-length protein. “TRIDs” are molecules exerting ribosome readthrough; for some, the mechanism of action is still under debate. We investigate a possible mechanism of action (MOA) by which our recently synthesized TRIDs, namely NV848, NV914, and NV930, could exert their readthrough activity by in silico analysis and in vitro studies. Our results suggest a likely inhibition of FTSJ1, a tryptophan tRNA-specific 2′-O-methyltransferase. Full article
(This article belongs to the Special Issue Molecular Approaches Fighting Nonsense II)
Show Figures

Figure 1

Back to TopTop